Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Recent studies in multiple epithelial cancers have shown that the inhibitory receptor programmed cell death 1 (PD-1) is expressed on tumor-infiltrating lymphocytes and/or programmed death ligand 1 (PD-L1) is expressed on tumor cells, suggesting that antitumor immunity may be modulated by the PD-1/PD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2014-07, Vol.146 (1), p.15-24
Hauptverfasser:	Muenst, S., Schaerli, A. R., Gao, F., Däster, S., Trella, E., Droeser, R. A., Muraro, M. G., Zajac, P., Zanetti, R., Gillanders, W. E., Weber, W. P., Soysal, S. D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over B cells B7-H1 Antigen - genetics B7-H1 Antigen - metabolism Breast cancer Breast Neoplasms - genetics Breast Neoplasms - metabolism Breast Neoplasms - mortality Breast Neoplasms - pathology Cancer research Cancer therapies Female Formaldehyde Gene Expression Humans Immunohistochemistry Immunophenotyping Ligands Medical diagnosis Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Neoplasm Grading Neoplasm Metastasis Neoplasm Staging Oncology Preclinical Study Prognosis Tissue Array Analysis Tumor Burden
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!